| Symbol |
Name |
|
ACOT11
|
acyl-CoA thioesterase 11
|
|
ADAM12
|
ADAM metallopeptidase domain 12
|
|
ADRB1
|
adrenoceptor beta 1
|
|
ADRB3
|
adrenoceptor beta 3
|
|
BMP6
|
bone morphogenetic protein 6
|
|
C19ORF80
|
chromosome 19 open reading frame 80
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
DIO2
|
deiodinase, iodothyronine, type II
|
|
DLK1
|
delta-like 1 homolog (Drosophila)
|
|
ENPP2
|
ectonucleotide pyrophosphatase/phosphodiesterase 2
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
FGF21
|
fibroblast growth factor 21
|
|
FNDC5
|
fibronectin type III domain containing 5
|
|
FTO
|
fat mass and obesity associated
|
|
GDF5
|
growth differentiation factor 5
|
|
HBEGF
|
heparin-binding EGF-like growth factor
|
|
IRF4
|
interferon regulatory factor 4
|
|
IRS1
|
insulin receptor substrate 1
|
|
KLF11
|
Kruppel-like factor 11
|
|
KLF15
|
Kruppel-like factor 15
|
|
LCT
|
lactase
|
|
LTA
|
lymphotoxin alpha
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MIR196A1
|
microRNA 196a-1
|
|
MIR196A2
|
microRNA 196a-2
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
NAT8L
|
N-acetyltransferase 8-like (GCN5-related, putative)
|
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2
|
|
NRG4
|
neuregulin 4
|
|
PAX3
|
paired box 3
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PRDM16
|
PR domain containing 16
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
RBM4
|
RNA binding motif protein 4
|
|
TP53
|
tumor protein p53
|
|
UCP1
|
uncoupling protein 1 (mitochondrial, proton carrier)
|
|
USP6
|
ubiquitin specific peptidase 6
|
